Merck’s Drug Approved for EU Market $MRK $XHS

/ Healthcare / By

European regulators have approved Merck & Co Inc’s immune system-boosting cancer drug Keytruda for marketing in Europe.

The Drug;Pembrolizumab was also approved by EMA on Friday.

View the full release here.